Switzerland / Lonza Goes Big with Investments in Biologics, ADCs & Vaccines Manufacturing
In the last month alone, CDMO giant Lonza has announced three major upgrades to its manufacturing footprint in…
Top Stories
Turkey / Koçak Farma & The Push for Homegrown COVID-19 Vaccines
As the international community continues its quest to vaccinate the global population against COVID-19, shortages of already approved vaccines have put many countries on the waiting list. Approved vaccines from…
APAC / Top Pharma Markets Ranking
The Top 10 pharma markets in the vast Asia-Pacific region, ranked by market size in USD millions for 2018. China is…
Japan / Takeda’s Revenue up 5x; First Domestic COVID-19 Vaccine; Industry Opposes IP Waiver
The latest from Japanese pharma, including Takeda’s big profit jump, British Linepharma’s quest to get the…
Canada / Top 10 Pharma Companies 2020 Ranking
The Top 10 companies in the Canadian pharma market for 2020, ranked by revenues in USD billions. J&J takes the…
USA / U-Turn as Biden Pledges Support for Waiver on COVID-19 Vaccine IP
In a shock move, Joe Biden’s administration looks set to support a waiver on intellectual property (IP)…
APAC / How Precision Medicine is Transforming the Oncology Landscape
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year and with deaths caused by cancer…
In Conversation
Susanne Caspar – CEO, Linnea
Susanne Caspar, CEO at Swiss natural API producer Linnea, talks about her first few months in the company, the pharmaceutical industry’s growing embrace of natural ingredients, and why Linnea has made the move into cannabis API production. 2020 was defined by an increase in demand for dietary supplements because of COVID-19, with people looking for ways to manage stress,…
Latest Reports
Focus on China
Public Insurance Coverage for Rare Disease Patients in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
Boehringer Ingelheim’s Stroke Rehab Centre Success…
In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas…
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
Top 10 Chinese Pharma Companies 2020
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken…
Read more: China >>
Focus on Singapore
APAC: How Precision Medicine is Transforming the Oncology…
Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year…
The Challenges of Regulatory Convergence in APAC Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific…
Medtech’s Post-COVID Paradigm in APAC
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
Singapore: Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long…
Read more: Singapore >>
Focus on Vaccines
Moderna: Bullish Bancel “Not Losing Sleep” over COVID-19…
The day the Biden administration announced its support for the waiver of IP…
US U-Turn as Biden Pledges Support for Waiver on COVID-19…
In a shock move, Joe Biden’s administration looks set to support a waiver on…
Lonza Goes Big with Swiss Investments in Biologics, ADCs…
In the last month alone, CDMO giant Lonza has announced three major upgrades to…
Turkey: Koçak Farma & The Push for Homegrown COVID-19…
As the international community continues its quest to vaccinate the global…
Read more: Vaccines >>
Focus on USA
Moderna: Bullish Bancel “Not Losing Sleep” over COVID-19…
The day the Biden administration announced its support for the waiver of IP…
USA: 2 Things the Biden Administration can do Now to Lower…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can…
Novavax: From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
US U-Turn as Biden Pledges Support for Waiver on COVID-19…
In a shock move, Joe Biden’s administration looks set to support a waiver on…
Read more: USA >>
Focus on Switzerland
Switzerland’s Quest for Alternatives to Animal Testing of…
Animal testing for medicinal purposes is back under the spotlight in Switzerland…
Lonza Goes Big with Swiss Investments in Biologics, ADCs…
In the last month alone, CDMO giant Lonza has announced three major upgrades to…
Switzerland: A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
Read more: Switzerland >>
Focus on Europe
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
Vaccine Wars: What the EU/AstraZeneca Row Shows Us About…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and…
MSD Switzerland AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich…
Switzerland Biotech Listing Snapshot 2021
The SXI Bio & MedTech Index outperformed the Swiss Performance Index (SPI)…
Read more: Europe >>
Focus on MEA
MENA Pharma News: Egypt Opens ‘Pharma City’;…
The latest Middle East and North Africa (MENA) pharma, including Egypt’s…
Turkey: Koçak Farma & The Push for Homegrown COVID-19…
As the international community continues its quest to vaccinate the global…
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…